A phase I trial of low-dose inhaled carbon monoxide in sepsis-induced ARDS.
Fredenburgh LE, Perrella MA, Barragan-Bradford D, Hess DR, Peters E, Welty-Wolf KE, Kraft BD, Harris RS, Maurer R, Nakahira K, Oromendia C, Davies JD, Higuera A, Schiffer KT, Englert JA, Dieffenbach PB, Berlin DA, Lagambina S, Bouthot M, Sullivan AI, Nuccio PF, Kone MT, Malik MJ, Porras MAP, Finkelsztein E, Winkler T, Hurwitz S, Serhan CN, Piantadosi CA, Baron RM, Thompson BT, Choi AM.
Fredenburgh LE, et al. Among authors: kraft bd.
JCI Insight. 2018 Dec 6;3(23):e124039. doi: 10.1172/jci.insight.124039.
JCI Insight. 2018.
PMID: 30518685
Free PMC article.
Clinical Trial.